Literature DB >> 7713310

Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.

J van den Born1, A A van Kraats, M A Bakker, K J Assmann, L P van den Heuvel, J H Veerkamp, J H Berden.   

Abstract

In the present study we investigated whether glomerular hyperfiltration and albuminuria in streptozotocin-induced diabetic nephropathy in male Wistar-Münich rats are associated with changes in the heparan sulphate content of the glomerular basement membrane. Rats with a diabetes mellitus duration of 8 months, treated with low doses of insulin, showed a significant increase in glomerular filtration rate (p < 0.01) and effective renal plasma flow (p < 0.05), without alterations in filtration fraction or mean arterial blood pressure. Diabetic rats developed progressive albuminuria (at 7 months, diabetic rats (D): 42 +/- 13 vs control rats (C): 0.5 +/- 0.2 mg/24 h, p < 0.002) and a decrease of the selectivity index (clearance IgG/clearance albumin) of the proteinuria (at 7 months, D: 0.20 +/- 0.04 vs C: 0.39 +/- 0.17, p < 0.05), suggesting loss of glomerular basement membrane charge. Light- and electron microscopy demonstrated a moderate increase of mesangial matrix and thickening of the glomerular basement membrane in the diabetic rats. Immunohistochemically an increase of laminin, collagen III and IV staining was observed in the mesangium and in the glomerular basement membrane, without alterations in glomerular basement membrane staining of heparan sulphate proteoglycan core protein or heparan sulphate. Glomerular basement membrane heparan sulphate content, quantitated in individual glomerular extracts by a new inhibition ELISA using a specific anti-glomerular basement membrane heparan sulphate monoclonal antibody (JM403), was not altered (median (range) D: 314 (152-941) vs C: 262 (244-467) ng heparan sulphate/mg glomerulus). However, the amount of glomerular 4-hydroxyproline, as a measure for collagen content, was significantly increased (D: 1665 (712-2014) vs C: 672 (515-1208) ng/mg glomerulus, p < 0.01). Consequently, a significant decrease of the heparan sulphate/4-hydroxyproline ratio (D: 0.21 (0.14-1.16) vs C: 0.39 (0.30-0.47), p < 0.05) was found. In summary, we demonstrate that in streptozotocin-diabetic rats glomerular hyperfiltration and a progressive, selective proteinuria are associated with a relative decrease of glomerular basement membrane heparan sulphate. Functionally, a diminished heparan sulphate-associated charge density within the glomerular basement membrane might explain the selective proteinuria in the diabetic rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713310     DOI: 10.1007/bf00400090

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  66 in total

1.  Steady state measurement of glomerular proteoglycan synthesis in streptozotocin-induced diabetes.

Authors:  J Warren; R M Mason
Journal:  Biochem Soc Trans       Date:  1992-05       Impact factor: 5.407

Review 2.  Biosynthesis of heparin and heparan sulfate.

Authors:  U Lindahl; M Kusche; K Lidholt; L G Oscarsson
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

3.  Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats.

Authors:  A S Reddi; R Ramamurthi; M Miller; S Dhuper; N Lasker
Journal:  Biochem Med Metab Biol       Date:  1991-02

4.  Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

Authors:  R Zatz; B R Dunn; T W Meyer; S Anderson; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

5.  Effect of diabetes on in vivo metabolism of [35S]-labeled glomerular basement membrane.

Authors:  M P Cohen; M L Surma
Journal:  Diabetes       Date:  1984-01       Impact factor: 9.461

6.  Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus.

Authors:  R L Vernier; M W Steffes; S Sisson-Ross; S M Mauer
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

7.  ECM gene expression and its modulation by insulin in diabetic rats.

Authors:  M Fukui; T Nakamura; I Ebihara; I Shirato; Y Tomino; H Koide
Journal:  Diabetes       Date:  1992-12       Impact factor: 9.461

8.  Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy.

Authors:  H Makino; S Ikeda; T Haramoto; Z Ota
Journal:  Nephron       Date:  1992       Impact factor: 2.847

9.  Glomerular proteoglycans in diabetes. Partial structural characterization and metabolism of de novo synthesized heparan-35SO4 and dermatan-35SO4 proteoglycans in streptozocin-induced diabetic rats.

Authors:  D J Klein; D M Brown; T R Oegema
Journal:  Diabetes       Date:  1986-10       Impact factor: 9.461

10.  Nonenzymatic glycation of fibronectin and alterations in the molecular association of cell matrix and basement membrane components in diabetes mellitus.

Authors:  J F Tarsio; B Wigness; T D Rhode; W M Rupp; H Buchwald; L T Furcht
Journal:  Diabetes       Date:  1985-05       Impact factor: 9.461

View more
  10 in total

1.  Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.

Authors:  J van den Born; A A van Kraats; M A Bakker; K J Assmann; H B Dijkman; J A van der Laak; J H Berden
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

2.  Location of type XV collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney.

Authors:  P M Hägg; P O Hägg; S Peltonen; H Autio-Harmainen; T Pihlajaniemi
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

Review 3.  Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation.

Authors:  Dorin-Bogdan Borza
Journal:  Matrix Biol       Date:  2016-09-06       Impact factor: 11.583

4.  Effects of advanced glycosylation endproducts on perlecan core protein of glomerular epithelium.

Authors:  Tae-Sun Ha; Chang-Ju Song; Joon-Ho Lee
Journal:  Pediatr Nephrol       Date:  2004-09-22       Impact factor: 3.714

5.  Preventive effect of taurine on experimental type II diabetic nephropathy.

Authors:  Shumei Lin; Jiancheng Yang; Gaofeng Wu; Mei Liu; Xinhong Luan; Qiufeng Lv; He Zhao; Jianmin Hu
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

6.  Preclinical and clinical evidence of nephro- and cardiovascular protective effects of glycosaminoglycans.

Authors:  Arrigo F Cicero; Sibel Ertek
Journal:  Arch Med Sci       Date:  2010-09-07       Impact factor: 3.318

Review 7.  Basement Membrane Defects in Genetic Kidney Diseases.

Authors:  Christine Chew; Rachel Lennon
Journal:  Front Pediatr       Date:  2018-01-29       Impact factor: 3.418

8.  Urinary Proteome Analysis Identified Neprilysin and VCAM as Proteins Involved in Diabetic Nephropathy.

Authors:  Elena Guillén-Gómez; Beatriz Bardají-de-Quixano; Sílvia Ferrer; Carlos Brotons; Mark A Knepper; Montserrat Carrascal; Joaquin Abian; José M Mas; Francesca Calero; José A Ballarín; Patricia Fernández-Llama
Journal:  J Diabetes Res       Date:  2018-04-29       Impact factor: 4.011

9.  Differential expression of parietal epithelial cell and podocyte extracellular matrix proteins in focal segmental glomerulosclerosis and diabetic nephropathy.

Authors:  Gek Cher Chan; Diana G Eng; Jeffrey H Miner; Charles E Alpers; Kelly Hudkins; Anthony Chang; Jeffrey W Pippin; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2019-10-21

10.  Erytrocyte membrane anionic charge in type 2 diabetic patients with retinopathy.

Authors:  Yasemin Budak; Hakan Demirci; Muberra Akdogan; Dilek Yavuz
Journal:  BMC Ophthalmol       Date:  2004-10-08       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.